Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alterome Therapeutics, Inc.
Emory University
Nuvectis Pharma, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tagworks Pharmaceuticals BV
Boehringer Ingelheim
Pheon Therapeutics
Pheon Therapeutics
National Institutes of Health Clinical Center (CC)
Akamis Bio
Adaptimmune
National Institutes of Health Clinical Center (CC)
Seattle Children's Hospital
Seattle Children's Hospital
Providence Health & Services
St. Jude Children's Research Hospital
SillaJen, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Washington University School of Medicine
University Health Network, Toronto
Nuvectis Pharma, Inc.
University of Pittsburgh
Akamis Bio
Akamis Bio
Sichuan University
Kiromic BioPharma Inc.
M.D. Anderson Cancer Center
Blueprint Medicines Corporation
Blueprint Medicines Corporation
National Cancer Institute (NCI)
Providence Health & Services
West China Hospital
Keystone Nano, Inc
Advaxis, Inc.
Kyowa Kirin Co., Ltd.
Pfizer
R-Pharm
China Medical University, China
Celon Pharma SA
National Institutes of Health Clinical Center (CC)
Myeloid Therapeutics
Celgene
Multitude Therapeutics Inc.
Cantargia AB
Blueprint Medicines Corporation
Oslo University Hospital
National Institutes of Health Clinical Center (CC)